ADDENDUM: Section E9 of the American College of Medical Genetics Technical Standards and Guidelines: Fluorescence in situ hybridization

Affiliations

¹ Genzyme Genetics, Santa Fe, NM, USA.
² University of Minnesota Medical School, Minneapolis, MN, USA.
³ Fullerton Genetics Center, Asheville, NC, USA.
⁴ Mayo Clinic College of Medicine, Rochester, MN, USA.
⁵ Oregon Health and Science University, Portland, OR, USA.
⁶ Kaiser Permanente, NW, Portland, OR, USA.
⁷ University of North Carolina, Chapel Hill, NC, USA.
⁸ Laboratory Corp America, Research Triangle Park, NC, USA.
⁹ Seattle Children's Hospital and University of Washington Medical Center, Seattle, WA, USA.

Free article

Comment

James T Mascarello et al. Genet Med. 2019 Oct.

Free article

. 2019 Oct;21(10):2405.

doi: 10.1038/s41436-019-0508-z.

¹ Genzyme Genetics, Santa Fe, NM, USA.
² University of Minnesota Medical School, Minneapolis, MN, USA.
³ Fullerton Genetics Center, Asheville, NC, USA.
⁴ Mayo Clinic College of Medicine, Rochester, MN, USA.
⁵ Oregon Health and Science University, Portland, OR, USA.
⁶ Kaiser Permanente, NW, Portland, OR, USA.
⁷ University of North Carolina, Chapel Hill, NC, USA.
⁸ Laboratory Corp America, Research Triangle Park, NC, USA.
⁹ Seattle Children's Hospital and University of Washington Medical Center, Seattle, WA, USA.

No abstract available

Comment on

Section E9 of the American College of Medical Genetics technical standards and guidelines: fluorescence in situ hybridization.
Mascarello JT, Hirsch B, Kearney HM, Ketterling RP, Olson SB, Quigley DI, Rao KW, Tepperberg JH, Tsuchiya KD, Wiktor AE; Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee. Mascarello JT, et al. Genet Med. 2011 Jul;13(7):667-75. doi: 10.1097/GIM.0b013e3182227295. Genet Med. 2011. PMID: 21738013